Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 6
1964 16
1965 6
1966 8
1967 3
1968 10
1969 14
1970 14
1971 10
1972 14
1973 16
1974 25
1975 24
1976 11
1977 17
1978 12
1979 8
1980 18
1981 21
1982 26
1983 23
1984 25
1985 27
1986 47
1987 34
1988 74
1989 65
1990 114
1991 93
1992 128
1993 90
1994 99
1995 113
1996 92
1997 128
1998 111
1999 100
2000 109
2001 134
2002 119
2003 108
2004 136
2005 124
2006 148
2007 134
2008 148
2009 99
2010 122
2011 113
2012 129
2013 140
2014 185
2015 164
2016 150
2017 159
2018 171
2019 156
2020 138
2021 162
2022 165
2023 186
2024 78

Text availability

Article attribute

Article type

Publication date

Search Results

4,776 results

Results by year

Filters applied: . Clear all
Page 1
Baveno VII - Renewing consensus in portal hypertension.
de Franchis R, Bosch J, Garcia-Tsao G, Reiberger T, Ripoll C; Baveno VII Faculty. de Franchis R, et al. J Hepatol. 2022 Apr;76(4):959-974. doi: 10.1016/j.jhep.2021.12.022. Epub 2021 Dec 30. J Hepatol. 2022. PMID: 35120736 Free PMC article. Review.
Among patients with compensated cirrhosis or compensated advanced chronic liver disease (cACLD - defined at the Baveno VI conference), the presence or absence of clinically significant portal hypertension (CSPH) is associated with differing outcomes, including risk …
Among patients with compensated cirrhosis or compensated advanced chronic liver disease (cACLD - defined at the Baveno VI conference), the p …
Porto-sinusoidal vascular disorder.
De Gottardi A, Sempoux C, Berzigotti A. De Gottardi A, et al. J Hepatol. 2022 Oct;77(4):1124-1135. doi: 10.1016/j.jhep.2022.05.033. Epub 2022 Jun 9. J Hepatol. 2022. PMID: 35690264 Free article. Review.
It is well established that portal hypertension can occur in the absence of cirrhosis, as reported in patients with immune disorders, infections and thrombophilia. However, similar histological abnormalities primarily affecting the hepatic sinusoidal and (peri)po
It is well established that portal hypertension can occur in the absence of cirrhosis, as reported in patients with immune dis …
Portal Hypertension and Related Complications: Diagnosis and Management.
Simonetto DA, Liu M, Kamath PS. Simonetto DA, et al. Mayo Clin Proc. 2019 Apr;94(4):714-726. doi: 10.1016/j.mayocp.2018.12.020. Mayo Clin Proc. 2019. PMID: 30947834 Review.
The past several decades have seen major improvements in the clinical management of complications of portal hypertension, resulting in substantial gains in patient outcomes. ...This review focuses on the pathophysiology and diagnosis of portal hypertension
The past several decades have seen major improvements in the clinical management of complications of portal hypertension, resu …
Causes and Management of Non-cirrhotic Portal Hypertension.
Gioia S, Nardelli S, Ridola L, Riggio O. Gioia S, et al. Curr Gastroenterol Rep. 2020 Sep 17;22(12):56. doi: 10.1007/s11894-020-00792-0. Curr Gastroenterol Rep. 2020. PMID: 32940785 Free PMC article. Review.
PURPOSE OF THE REVIEW: Non-cirrhotic portal hypertension (NCPH) includes a heterogeneous group of conditions. ...To now, the management of portal hypertension-related complications in NCPH is the same of those of cirrhosis. ...
PURPOSE OF THE REVIEW: Non-cirrhotic portal hypertension (NCPH) includes a heterogeneous group of conditions. ...To now, the m …
Non-cirrhotic portal hypertension - diagnosis and management.
Khanna R, Sarin SK. Khanna R, et al. J Hepatol. 2014 Feb;60(2):421-41. doi: 10.1016/j.jhep.2013.08.013. Epub 2013 Aug 23. J Hepatol. 2014. PMID: 23978714 Free article. Review.
In EHPVO, there are additional concerns of growth faltering, portal biliopathy, MHE and parenchymal dysfunction. Surgical shunts are indicated in patients with failure of endotherapy, bleeding from sites not amenable to endotherapy, symptomatic hypersplenism or symptomatic …
In EHPVO, there are additional concerns of growth faltering, portal biliopathy, MHE and parenchymal dysfunction. Surgical shunts are …
Portal hypertension: pathophysiology, diagnosis and management.
Bloom S, Kemp W, Lubel J. Bloom S, et al. Intern Med J. 2015 Jan;45(1):16-26. doi: 10.1111/imj.12590. Intern Med J. 2015. PMID: 25230084 Review.
Portal hypertension is an important complication of liver disease. ...This review outlines the pathogenesis and diagnosis of portal hypertension and outlines the management of these various important clinical sequelae. ...
Portal hypertension is an important complication of liver disease. ...This review outlines the pathogenesis and diagnosis of
Pathophysiology of portal hypertension.
Iwakiri Y. Iwakiri Y. Clin Liver Dis. 2014 May;18(2):281-91. doi: 10.1016/j.cld.2013.12.001. Epub 2014 Feb 25. Clin Liver Dis. 2014. PMID: 24679494 Free PMC article. Review.
Portal hypertension is a major complication of liver disease that results from a variety of pathologic conditions that increase the resistance to the portal blood flow into the liver. ...In addition, the future directions of basic/clinical research in port
Portal hypertension is a major complication of liver disease that results from a variety of pathologic conditions that increas
Hepatic microcirculation and mechanisms of portal hypertension.
Gracia-Sancho J, Marrone G, Fernández-Iglesias A. Gracia-Sancho J, et al. Nat Rev Gastroenterol Hepatol. 2019 Apr;16(4):221-234. doi: 10.1038/s41575-018-0097-3. Nat Rev Gastroenterol Hepatol. 2019. PMID: 30568278 Review.
Liver microcirculatory dysfunction is one of the key mechanisms that promotes the progression of chronic liver disease (also termed cirrhosis) and the development of its major clinical complication, portal hypertension. In the present Review, we describe the current …
Liver microcirculatory dysfunction is one of the key mechanisms that promotes the progression of chronic liver disease (also termed cirrhosi …
Cirrhotic portal hypertension: From pathophysiology to novel therapeutics.
Gunarathne LS, Rajapaksha H, Shackel N, Angus PW, Herath CB. Gunarathne LS, et al. World J Gastroenterol. 2020 Oct 28;26(40):6111-6140. doi: 10.3748/wjg.v26.i40.6111. World J Gastroenterol. 2020. PMID: 33177789 Free PMC article. Review.
Portal hypertension and bleeding from gastroesophageal varices is the major cause of morbidity and mortality in patients with cirrhosis. Portal hypertension is initiated by increased intrahepatic vascular resistance and a hyperdynamic circulatory state
Portal hypertension and bleeding from gastroesophageal varices is the major cause of morbidity and mortality in patients with
Portal hypertension: a review of portosystemic collateral pathways and endovascular interventions.
Pillai AK, Andring B, Patel A, Trimmer C, Kalva SP. Pillai AK, et al. Clin Radiol. 2015 Oct;70(10):1047-59. doi: 10.1016/j.crad.2015.06.077. Epub 2015 Jul 15. Clin Radiol. 2015. PMID: 26188844 Review.
Normal blood pressure within the portal system varies between 5 and 10 mmHg. Portal hypertension is defined when the gradient between the portal and systemic venous blood pressure exceeds 5 mmHg. The most common cause of portal hypertension
Normal blood pressure within the portal system varies between 5 and 10 mmHg. Portal hypertension is defined when the gr …
4,776 results